Mozziyar “Mozzi” Etemadi, MD, PhD, is supporting the transformation of healthcare delivery and patient care at Northwestern Medicine by bringing engineers into direct contact with clinical providers. In this episode, he talks about the explosion of artificial intelligence in healthcare in recent years and how Northwestern Medicine is using this technology to improve healthcare delivery and patient care.
Treating cancer has become increasingly difficult as cells develop resistance. Northwestern investigators have sought to address this issue on the cellular level through the development of a novel FateMap tool, used to predict the future behavior of cancer cells before they are exposed to cancer-fighting drugs. In this episode, Yogesh Goyal, PhD, discusses his latest research, published in Nature, and how his lab is addressing complex problems through an interdisciplinary approach.
The launch of the Simpson Querrey Lung Institute for Translational Science (SQLIFTS) aims to expedite the discovery and implementation of innovative lung disease treatments through a patient-centered, bedside-to-bench-to-bedside approach. In this episode, Scott Budinger, MD, the new executive director of the institute, discusses its launch and how it aims to transform lung disease research and clinical care.
Recently, Northwestern Medicine investigators have discovered novel genetic factors contributing to the risk of Parkinson’s disease, which may lead to potential therapeutic targets. Steven Lubbe, PhD, assistant professor of Neurology at Feinberg, discusses these findings recently published in the journal Brain.
Disrupting our internal clocks can lead to diseases such as obesity and diabetes. Scientists at Northwestern have uncovered the mechanism behind why late-night eating is linked to weight gain and diabetes. Joseph Bass, MD, PhD, led the study published in the journal Science.
There’s strong evidence that physical activity can play an important role in the health and lifespan of cancer survivors. Siobhan Phillips, PhD, MPH, leads the Exercise and Health Lab at Feinberg, which designs, tests, implements and disseminates physical activity interventions to support cancer survivors.
Skin diseases from psoriasis to melanoma affect as many as one in three Americans at any given time. Kathleen Green, PhD, has greatly advanced basic molecular research related to skin diseases. She discusses recent discoveries in her lab that could lead to future therapeutic targets.
Northwestern scientists Yuan Luo, PhD, and Catherine Gao, MD, discuss a study they conducted using the artificial intelligence chatbot, ChatGPT. The results showcase the online tool’s ability to produce convincing medical research abstracts. They also discuss the tool’s potential to help with writing-intensive tasks in healthcare and medical research.
Ann Kennedy, PhD, is a theoretical neuroscientist, investigating neural computation and the structure of behavior. In this episode, she talks about her recent research in the area of aggression and how it’s regulated in the brains of animals. She was recently named the winner of the 2022 Eppendorf and Science Prize for Neurobiology.
To have the greatest impact on human health, biomedical research findings and evidence-based practices need to be implemented into routine healthcare. What is implementation science, and how can we ensure research successfully makes an impact? Rinad Beidas, PhD, and Sara Becker, PhD, discuss the field and its future as a research priority at Feinberg.
